A new clinical study by the Department of Psychosomatic Medicine and Psychotherapy at the University Hospital of Tübingen has confirmed that the bacterial culture 1714® (1714-Serenitas®) can both improve stress processing and make it easier for healthy people to deal with stress.
This clinical trial showed for the first time that the 1714® culture enables better stress management by changing brain processing in response to stress.
For the study, 40 healthy people took either 1714® or a placebo daily for four weeks. They were exposed to a social stressor before and after the four-weeks and their brain activity was measured.
The clinical trial showed clearly that the 1714® strain produces changes in the brain that are linked with stress regulation, indicating improved coping with stressful situations.
The trial also showed that 1714® can produce changes in the brain regions associated with stress management, stimulating the coping centres in the brain.
The findings show for the first time that the unique 1714® culture exerts a positive influence on stress management, by changing how stress is processed within the brain.
These results are only valid for the 1714® culture and can not be transferred to all other cultures
The scientists who conducted the clinical trial concluded that 1714® (1714-Serenitas®)